vimarsana.com
Home
Live Updates
Byondis and medac Enter Into License and Collaboration and S
Byondis and medac Enter Into License and Collaboration and S
Byondis and medac Enter Into License and Collaboration and Supply Agreements for Anti-HER2 ADC Trastuzumab Duocarmazine (SYD985)
/PRNewswire/ -- Byondis B.V., an independent, Dutch clinical stage biopharmaceutical company creating precision medicines, has entered into a License and...
Related Keywords
Germany ,
Netherlands ,
Nijmegen ,
Gelderland ,
Marco Timmers ,
Jacques Lemmens ,
,
Byondis Founder ,
Chairman Jacques Lemmens ,
Managing Director ,
Marketing Authorization Application ,
Next Generation Antibody Drug ,
Good Manufacturing Practice ,
Byondisbv ,